However, as the clinical value of serum CgA and NSE are well established for neuroendocrine tumors (NETs) [120,121], the elevation of these markers can also be observed in a number of other tumor types [122–124] and benign diseases [125–129] and therefore, do not appear as neuron-specific as considered previously. Here, ENO2 is linked to neoplasm.